|
TTD
Drug ID:
DCL001021
| Drug
Information |
| Name | Tramadol ER | | Company | TheraQuest Biosciences | | Indication | Neuropathic pain, Postherpetic neuralgia | Phase III completed [1] | | Therapeutic Class | Analgesics | | CAS Number | CAS 27203-92-5 | | Formular | C16H25NO2 | | SuperDrug ATC ID | N02AX02; | | SuperDrug CAS ID | 027203925; | | ClinicalTrials.gov | NCT00347685; | | Target | Mu-type opioid receptor |  | Agonist | [1] | | Mu-type opioid receptor |  | Multitarget | [1] | | Noradrenaline uptake |  | Inhibitor | [1] | | Noradrenaline uptake |  | Multitarget | [1] | | Serotonin reuptake |  | Inhibitor | [1] | | Serotonin reuptake |  | Multitarget | [1] | | Ref 1 | Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|